• Iron-Dependent KDM4D Regulates MSC Quiescence via PI3K-Akt-F

  2026-06-11

  This study reveals that iron-dependent KDM4D activity controls the balance between quiescent and active mesenchymal stem cells (MSCs) through the PI3K-Akt-Foxo1 signaling pathway. The findings provide mechanistic insight into how iron deficiency impairs MSC mobilization and bone remodeling, which has implications for osteoporosis and metabolic bone disease research.

• Targeting Fructose Metabolism and the Polyol Pathway in Canc

  2026-06-11

  This review highlights how dysregulated fructose metabolism, specifically via the polyol pathway and its enzymatic drivers like aldose reductase, underpins malignancy in several aggressive cancers. By dissecting metabolic reprogramming and linking it to potential therapeutic strategies, the findings support targeting these pathways—providing a mechanistic rationale for tools such as Epalrestat in translational research.

• Dinaciclib (SCH727965): Reliable CDK Inhibition for Cancer R

  2026-06-10

  This article provides practical, scenario-driven guidance for leveraging Dinaciclib (SCH727965), SKU A8412, in cell cycle and apoptosis studies. It addresses laboratory challenges—including assay reproducibility, protocol optimization, and vendor selection—backed by quantitative data and literature. Researchers gain actionable strategies for maximizing the reliability and interpretability of Dinaciclib-driven experiments.

• Cyanine 3-dCTP: Advanced Fluorescent Labeling for High-Fidel

  2026-06-10

  Explore how Cy3-dCTP (Cyanine 3-deoxycytidine triphosphate) enables precise, efficient DNA and cDNA labeling in enzymatic synthesis workflows. This article delivers unique insights into practical assay optimization, integrating recent advances in DNA framework engineering and referencing the latest scientific breakthroughs.

• KN-62: Strategic CaMKII Inhibition for Translational Impact

  2026-06-09

  Explore how KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine from APExBIO, enables transformative advances in calcium signaling research. This article provides mechanistic insight, experimental strategy, and translational guidance for leveraging selective CaMKII inhibition in metabolic, neurobiological, and disease-modeling workflows.

• Sulfo-Cy5 NHS Ester: Precision Protein Labeling for Imaging

  2026-06-09

  Sulfo-Cy5 NHS ester enables reliable, highly water-soluble protein conjugation for fluorescence imaging—unlocking robust labeling even with solvent-sensitive biomolecules. This guide covers advanced workflows, troubleshooting, and how recent immuno-oncology breakthroughs inform optimal assay design.

• Zosuquidar (LY335979): Revolutionizing MDR Reversal in Cance

  2026-06-08

  Zosuquidar (LY335979) empowers researchers to counter multidrug resistance (MDR) in cancer by selectively inhibiting the P-glycoprotein efflux pump. This article guides you from optimized in vitro workflows to troubleshooting and advanced applications, leveraging both cutting-edge studies and practical lab insights.

• URB597 (KDS-4103): Translating FAAH Inhibition Into Pain Sol

  2026-06-08

  This thought-leadership article explores the mechanistic underpinnings and strategic applications of URB597 (KDS-4103) as a selective FAAH inhibitor in translational pain and neuroinflammation research. Blending insights from recent cannabidiol (CBD) findings with actionable protocols, the article guides researchers in leveraging endocannabinoid modulation to address complex sensory and affective pain dimensions, while highlighting APExBIO’s commitment to research quality.

• V5 Epitope Tag Peptide: Precision Tools for Single-Molecule

  2026-06-07

  Explore the V5 Epitope Tag Peptide and its GKPIPNPLLGLDST sequence as a precision tool for protein tagging and single-molecule detection. This article unveils advanced assay strategies, practical insights from cutting-edge antibody screening, and practical protocol guidance for robust recombinant protein research.

• Bone Transport Accelerates Diabetic Ulcer Healing via TGF-β1

  2026-06-06

  This study demonstrates that bone transport surgery markedly accelerates diabetic foot ulcer healing through activation of the TGF-β1/TGFBR1 signaling pathway, coupling angiogenesis and immune modulation. The findings provide mechanistic insights for targeted interventions in chronic wound models, highlighting the therapeutic relevance of TGF-beta1 pathway modulation.

• AT-406 (SM-406): Optimizing Apoptosis Workflows in Cancer Re

  2026-06-05

  Harnessing the potent, orally bioavailable IAP antagonist AT-406 (SM-406) can revolutionize apoptosis pathway activation and drug sensitization in cancer models. This guide delivers actionable protocols, advanced workflow enhancements, and troubleshooting tips rooted in the latest research and product data.

• Protoporphyrin IX in Photodynamic Cancer Research: Protocols

  2026-06-05

  Explore how high-purity Protoporphyrin IX from APExBIO empowers precise photodynamic and ferroptosis assays. This guide details optimized workflows, troubleshooting strategies, and integrates insights from the latest research on iron metabolism resistance in cancer.

• Pol II Degradation Triggers Apoptosis Independent of Transcr

  2026-06-04

  The referenced study demonstrates that targeted degradation of RNA Polymerase II (Pol II) initiates cell death through mechanisms distinct from simple transcriptional shutdown. This discovery refines our understanding of apoptosis regulation and suggests new avenues for manipulating proteasome-regulated cellular processes in cancer research.

• Foretinib (GSK1363089): Enhancing Cancer Assay Precision

  2026-06-04

  Foretinib (GSK1363089) is redefining multikinase inhibition in cancer research with robust, reproducible inhibition of tumor growth and metastatic spread. This guide delivers actionable workflow enhancements and troubleshooting strategies, directly informed by advanced in vitro drug response methodologies.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-06-03

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) addresses the challenge of efficient amide bond formation in aqueous peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is suitable exclusively for in vitro protocols and should not be used in in vivo or clinical settings due to lack of supporting data.

3469 records 11/232 page Previous Next First page 上5页 1112131415 下5页 Last page